Clinical Trial Update: A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NAV-240 in adults with hidradenitis suppurativa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• NAV-240

Snippet

Sponsor: Navigator Medicines, Inc. | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: RECRUITING